IRMD
Price
$94.16
Change
-$3.82 (-3.90%)
Updated
Feb 4, 02:46 PM (EDT)
Capitalization
1.25B
Earnings call today
Intraday BUY SELL Signals
MASI
Price
$136.93
Change
-$2.20 (-1.58%)
Updated
Feb 4, 02:59 PM (EDT)
Capitalization
7.47B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IRMD vs MASI

Header iconIRMD vs MASI Comparison
Open Charts IRMD vs MASIBanner chart's image
iRadimed
Price$94.16
Change-$3.82 (-3.90%)
Volume$438
Capitalization1.25B
Masimo
Price$136.93
Change-$2.20 (-1.58%)
Volume$728
Capitalization7.47B
IRMD vs MASI Comparison Chart in %
IRMD
Daily Signal:
Gain/Loss:
MASI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IRMD vs. MASI commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a Hold and MASI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (IRMD: $97.98 vs. MASI: $139.13)
Brand notoriety: IRMD and MASI are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: IRMD: 70% vs. MASI: 93%
Market capitalization -- IRMD: $1.25B vs. MASI: $7.47B
IRMD [@Medical/Nursing Services] is valued at $1.25B. MASI’s [@Medical/Nursing Services] market capitalization is $7.47B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $189.57B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 2 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).

  • IRMD’s FA Score: 2 green, 3 red.
  • MASI’s FA Score: 1 green, 4 red.
According to our system of comparison, IRMD is a better buy in the long-term than MASI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 3 TA indicator(s) are bullish while MASI’s TA Score has 6 bullish TA indicator(s).

  • IRMD’s TA Score: 3 bullish, 5 bearish.
  • MASI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MASI is a better buy in the short-term than IRMD.

Price Growth

IRMD (@Medical/Nursing Services) experienced а -1.86% price change this week, while MASI (@Medical/Nursing Services) price change was +0.88% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -0.31%, and the average quarterly price growth was +14.02%.

Reported Earning Dates

IRMD is expected to report earnings on Feb 04, 2026.

MASI is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($7.47B) has a higher market cap than IRMD($1.25B). MASI has higher P/E ratio than IRMD: MASI (116.80) vs IRMD (59.38). MASI YTD gains are higher at: 6.974 vs. IRMD (0.720). IRMD has higher annual earnings (EBITDA): 25.8M vs. MASI (-73.3M). IRMD has less debt than MASI: IRMD (0) vs MASI (586M). MASI has higher revenues than IRMD: MASI (2.18B) vs IRMD (80.5M).
IRMDMASIIRMD / MASI
Capitalization1.25B7.47B17%
EBITDA25.8M-73.3M-35%
Gain YTD0.7206.97410%
P/E Ratio59.38116.8051%
Revenue80.5M2.18B4%
Total CashN/A312M-
Total Debt0586M-
FUNDAMENTALS RATINGS
IRMD vs MASI: Fundamental Ratings
IRMD
MASI
OUTLOOK RATING
1..100
8178
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
11100
SMR RATING
1..100
4097
PRICE GROWTH RATING
1..100
4260
P/E GROWTH RATING
1..100
1717
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (62) in the Medical Specialties industry is in the same range as MASI (89). This means that IRMD’s stock grew similarly to MASI’s over the last 12 months.

IRMD's Profit vs Risk Rating (11) in the Medical Specialties industry is significantly better than the same rating for MASI (100). This means that IRMD’s stock grew significantly faster than MASI’s over the last 12 months.

IRMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for MASI (97). This means that IRMD’s stock grew somewhat faster than MASI’s over the last 12 months.

IRMD's Price Growth Rating (42) in the Medical Specialties industry is in the same range as MASI (60). This means that IRMD’s stock grew similarly to MASI’s over the last 12 months.

IRMD's P/E Growth Rating (17) in the Medical Specialties industry is in the same range as MASI (17). This means that IRMD’s stock grew similarly to MASI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRMDMASI
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
Bullish Trend 2 days ago
65%
Declines
ODDS (%)
Bearish Trend 8 days ago
54%
Bearish Trend 7 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
IRMD
Daily Signal:
Gain/Loss:
MASI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DAEMX19.000.26
+1.39%
Dunham Emerging Markets Stock A
FSAGX64.65N/A
N/A
Fidelity Select Gold
FMFMX16.22N/A
N/A
Fidelity Advisor Series Equity Gr
RLBEX38.33-0.17
-0.44%
American Funds American Balanced R4
TGDVX15.25-0.07
-0.46%
TCW Relative Value Large Cap N

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
-1.03%
HBIO - IRMD
45%
Loosely correlated
-0.42%
TWST - IRMD
41%
Loosely correlated
-1.05%
BIO - IRMD
40%
Loosely correlated
+0.52%
ICUI - IRMD
40%
Loosely correlated
-0.50%
MASI - IRMD
40%
Loosely correlated
+0.51%
More

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with SYK. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
+0.51%
SYK - MASI
51%
Loosely correlated
-1.99%
BSX - MASI
48%
Loosely correlated
-0.27%
VCYT - MASI
47%
Loosely correlated
-1.10%
ISRG - MASI
46%
Loosely correlated
-3.59%
ENOV - MASI
44%
Loosely correlated
-1.71%
More